NeueHealth (NEUE) Competitors $6.75 0.00 (0.00%) As of 10/14/2025 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NEUE vs. JRVR, KINS, HIT, GOCO, RDZN, CCG, AAME, HUIZ, ZBAO, and TIRXShould you be buying NeueHealth stock or one of its competitors? The main competitors of NeueHealth include James River Group (JRVR), Kingstone Companies (KINS), Health In Tech (HIT), GoHealth (GOCO), Roadzen (RDZN), Cheche Group (CCG), Atlantic American (AAME), Huize (HUIZ), Zhibao Technology (ZBAO), and Tian Ruixiang (TIRX). These companies are all part of the "insurance" industry. NeueHealth vs. Its Competitors James River Group Kingstone Companies Health In Tech GoHealth Roadzen Cheche Group Atlantic American Huize Zhibao Technology Tian Ruixiang James River Group (NASDAQ:JRVR) and NeueHealth (NYSE:NEUE) are both small-cap insurance companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, media sentiment, dividends, analyst recommendations and valuation. Which has more volatility & risk, JRVR or NEUE? James River Group has a beta of 0.01, suggesting that its share price is 99% less volatile than the S&P 500. Comparatively, NeueHealth has a beta of 0.59, suggesting that its share price is 41% less volatile than the S&P 500. Which has better earnings & valuation, JRVR or NEUE? James River Group has higher earnings, but lower revenue than NeueHealth. James River Group is trading at a lower price-to-earnings ratio than NeueHealth, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJames River Group$707.63M0.35-$81.12M-$3.16-1.70NeueHealth$890.44M0.07-$134.68M-$15.97-0.42 Do institutionals & insiders believe in JRVR or NEUE? 95.2% of James River Group shares are owned by institutional investors. Comparatively, 63.9% of NeueHealth shares are owned by institutional investors. 33.8% of James River Group shares are owned by company insiders. Comparatively, 63.3% of NeueHealth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media prefer JRVR or NEUE? In the previous week, James River Group had 3 more articles in the media than NeueHealth. MarketBeat recorded 3 mentions for James River Group and 0 mentions for NeueHealth. James River Group's average media sentiment score of 0.65 beat NeueHealth's score of 0.00 indicating that James River Group is being referred to more favorably in the media. Company Overall Sentiment James River Group Positive NeueHealth Neutral Do analysts recommend JRVR or NEUE? James River Group currently has a consensus target price of $6.06, indicating a potential upside of 13.11%. NeueHealth has a consensus target price of $7.00, indicating a potential upside of 3.66%. Given James River Group's stronger consensus rating and higher possible upside, analysts clearly believe James River Group is more favorable than NeueHealth.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score James River Group 1 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.14NeueHealth 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Is JRVR or NEUE more profitable? NeueHealth has a net margin of -9.08% compared to James River Group's net margin of -13.50%. NeueHealth's return on equity of 0.00% beat James River Group's return on equity.Company Net Margins Return on Equity Return on Assets James River Group-13.50% -1.97% -0.19% NeueHealth -9.08%N/A -13.01% SummaryJames River Group beats NeueHealth on 10 of the 16 factors compared between the two stocks. Get NeueHealth News Delivered to You Automatically Sign up to receive the latest news and ratings for NEUE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NEUE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NEUE vs. The Competition Export to ExcelMetricNeueHealthMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$60.94M$8.50B$6.15B$21.90BDividend YieldN/A2.14%5.72%3.62%P/E Ratio-0.4276.5629.4032.51Price / Sales0.0733.47502.1861.00Price / CashN/A21.3125.8218.06Price / Book-0.047.0412.474.66Net Income-$134.68M$247.60M$3.32B$1.02B7 Day PerformanceN/A-0.51%3.98%-0.48%1 Month Performance0.12%-1.55%10.94%-0.23%1 Year Performance20.03%10.67%63.28%10.58% NeueHealth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NEUENeueHealth1.2328 of 5 stars$6.75flat$7.00+3.7%N/A$60.94M$890.44M-0.421,252JRVRJames River Group2.3777 of 5 stars$5.48+5.2%$6.06+10.6%-25.4%$239.26M$707.63M-1.73640KINSKingstone Companies1.9468 of 5 stars$14.98+3.0%N/A+52.1%$205.75M$155.14M7.4990HITHealth In Tech1.4826 of 5 stars$3.50+4.5%$2.50-28.6%N/A$188.90M$26.69M0.0079Analyst UpgradeShort Interest ↑Gap UpGOCOGoHealth2.5295 of 5 stars$4.52+2.7%$12.00+165.5%-57.4%$125.88M$798.89M-1.262,261Positive NewsShort Interest ↑RDZNRoadzen2.7417 of 5 stars$1.36+20.4%$5.00+267.6%+62.2%$85.90M$44.30M-0.90324Positive NewsHigh Trading VolumeCCGCheche Group0.9231 of 5 stars$1.01-3.8%N/AN/A$68.30M$475.82M-9.18N/AGap DownAAMEAtlantic American1.1373 of 5 stars$2.93+3.5%N/A+81.4%$57.72M$188.23M29.30140Gap UpHUIZHuize1.1332 of 5 stars$3.56+0.8%$2.30-35.4%-83.3%$35.61M$171.10M118.671,640Positive NewsShort Interest ↓Gap UpZBAOZhibao TechnologyN/A$1.00+3.0%N/A-67.7%$30.58M$25.27M0.00148Short Interest ↑Gap UpTIRXTian Ruixiang0.4087 of 5 stars$1.10-9.8%N/A-90.8%$29.72M$3.22M0.0050News Coverage Related Companies and Tools Related Companies James River Group Alternatives Kingstone Companies Alternatives Health In Tech Alternatives GoHealth Alternatives Roadzen Alternatives Cheche Group Alternatives Atlantic American Alternatives Huize Alternatives Zhibao Technology Alternatives Tian Ruixiang Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NEUE) was last updated on 10/21/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored$4,200 gold is nice ... but here’s what most gold bugs are missingGold just surged past $4,200, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeueHealth, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeueHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NEUE Stock Alerts